ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 43 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,602 | -53.1% | 20,537 | -35.6% | 0.00% | – |
Q2 2023 | $114,241 | -8.5% | 31,911 | -44.3% | 0.00% | – |
Q1 2023 | $124,884 | -44.9% | 57,286 | +203.8% | 0.00% | – |
Q4 2022 | $226,850 | +39.2% | 18,857 | -24.8% | 0.00% | – |
Q3 2022 | $163,000 | -10.4% | 25,077 | -36.9% | 0.00% | – |
Q2 2022 | $182,000 | -70.2% | 39,737 | -43.7% | 0.00% | – |
Q1 2022 | $611,000 | -48.8% | 70,611 | -15.5% | 0.00% | – |
Q4 2021 | $1,194,000 | +137.8% | 83,530 | +266.2% | 0.00% | – |
Q3 2021 | $502,000 | +90.9% | 22,813 | +16.4% | 0.00% | – |
Q2 2021 | $263,000 | +47.8% | 19,604 | +11.6% | 0.00% | – |
Q1 2021 | $178,000 | +212.3% | 17,569 | +29.9% | 0.00% | – |
Q4 2020 | $57,000 | +2750.0% | 13,521 | +1831.6% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 700 | -5.8% | 0.00% | – |
Q1 2020 | $2,000 | -66.7% | 743 | -33.5% | 0.00% | – |
Q4 2019 | $6,000 | +50.0% | 1,117 | 0.0% | 0.00% | – |
Q3 2019 | $4,000 | 0.0% | 1,117 | -9.6% | 0.00% | – |
Q2 2019 | $4,000 | 0.0% | 1,236 | +10.7% | 0.00% | – |
Q1 2019 | $4,000 | +33.3% | 1,117 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 1,117 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | -37.5% | 1,117 | 0.0% | 0.00% | – |
Q2 2018 | $8,000 | +14.3% | 1,117 | 0.0% | 0.00% | – |
Q1 2018 | $7,000 | -30.0% | 1,117 | 0.0% | 0.00% | – |
Q4 2017 | $10,000 | -9.1% | 1,117 | 0.0% | 0.00% | – |
Q3 2017 | $11,000 | +22.2% | 1,117 | 0.0% | 0.00% | – |
Q2 2017 | $9,000 | +28.6% | 1,117 | 0.0% | 0.00% | – |
Q1 2017 | $7,000 | +16.7% | 1,117 | +21.8% | 0.00% | – |
Q4 2016 | $6,000 | +50.0% | 917 | +77.4% | 0.00% | – |
Q3 2016 | $4,000 | +300.0% | 517 | +417.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | -96.4% | 100 | -98.0% | 0.00% | – |
Q3 2015 | $28,000 | +2700.0% | 5,100 | +5000.0% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | – | 100 | 0.0% | 0.00% | – |
Q4 2014 | $0 | -100.0% | 100 | -96.7% | 0.00% | – |
Q2 2014 | $29,000 | -58.6% | 3,000 | -50.0% | 0.00% | – |
Q1 2014 | $70,000 | – | 6,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |